Nefazodone and neurotoxicity.
Yong
J N
JN
D000639:Amitriptyline / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology*; D002220:Carbamazepine / Q000009:adverse effects / Q000494:pharmacology; D019389:Cytochrome P-450 CYP2D6 / Q000187:drug effects; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D010879:Piperazines; D018967:Risperidone / Q000009:adverse effects / Q000494:pharmacology*; D014230:Triazoles / Q000009:adverse effects* / Q000494:pharmacology
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D010879:Piperazines; D014230:Triazoles; D000639:Amitriptyline; D002220:Carbamazepine; C051752:nefazodone; C004704:cyclobenzaprine; D019389:Cytochrome P-450 CYP2D6; D018967:Risperidone